Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 1.340
-0.145 (-9.76%)
Oct 22, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 1.74 billion as of October 21, 2026. It is the 19,946th most valuable company in the world and the 893rd biggest in Hong Kong. Its market cap has decreased by 36.14% in one year.
Market Cap
1.74B
Enterprise Value
1.63B
Revenue
496.42K
Global Rank
Country Rank
#893 Hong Kong
PE Ratio
1.74
ChartMarket Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 1.74B, a decrease of -88.43%. That is a compound annual growth rate of -35.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 1.74B | -42.71% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HJ Science | 2.57B |
| Jiangsu Recbio Technology | 2.41B |
| Antengene Corporation | 2.07B |
| Mabpharm | 2.06B |
| Shandong Boan Biotechnology | 1.93B |
| AIM Vaccine | 1.93B |
| HighTide Therapeutics | 1.80B |
| Guangzhou Innogen Pharmaceutical Group | 1.61B |